Jade Biosciences Inc (JBIO)

NASDAQ · Health Care

$14.06 -1.26% Close Oct 30, 2026 Live

Jade Biosciences stock today

Jade Biosciences closed at $14.06 on October 30, 2026, down 1.26% on the day. Over the past year it returned +42.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $694 million.

$10.00$20.00
NovJan 2026MarMayJulSep
Total return with dividends reinvested, to the close on Oct 30, 2026
PeriodJBIOS&P 500 (SPY)
1 month+0.1%-0.9%
3 months-29.7%+2.1%
Year to date-8.9%+11.7%
1 year+42.7%+12.4%
3 years-95.0%+88.5%
5 years-96.9%+76.0%

Key statistics

Market value
$694M
52-week range
$8.95 to $26.85
Next report
Nov 12, 2026 (estimated)

About Jade Biosciences

Develops biopharmaceutical therapies, primarily focused on specialty therapeutics and drug development.

Sector: Health Care

More on Jade Biosciences

No forecast, no recommendation. This page describes Jade Biosciences Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.